Meta Information

ID:elderberry

Name:Elderberry

Schema Version:2.4_uniform_evidence_2026_06_18

Created

2026-07-02T07:04:55Z

Model

phase-b-newfiles-claude-opus-4.8

Interactions

Target id:

/class/immunosuppressants

Target name:

Immunosuppressants

Severity:

minor

Interaction type:

adverse

Nature:

relative

Temporal spacing:

Hours before target:

0

Hours after target:

0

Description:

Elderberry stimulates immune cytokines and could theoretically oppose immunosuppressive therapy.

Actionable advice:

This is best used cautiously with immunosuppressants; it is worth discussing with a specialist.

Validation status:

validated_via_class_inference

Evidence tier:

tier_c

Evidence basis:

class_inference_summary

Evidence anchors:

Source url:

Established mechanism / class pharmacology (no single primary source quoted)

Exact phrase from label:

Elderberry upregulates inflammatory cytokines; theoretical opposition to immunosuppression. Low-certainty.

Label source:

Class inference

Action type:

monitor